Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B
Clinical trial NCT03491553 · COMPLETED
Trial details
- NCT number
- NCT03491553
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-06
- Primary completion
- 2019-03-22
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.